In conclusion, combining AOM, especially GLP-1 RAs, with surgical or endoscopic obesity treatments appears to enhance weight loss in patients with suboptimal outcomes. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.